Acacia Diversified Holdings, Inc. (ACCA) is a diversified holding company focused on the medical cannabis and hemp sector. The company conducts its operations through subsidiaries including MariJ Pharmaceuticals, Inc., which specializes in the extraction and processing of high-cannabidiol (CBD)/low-tetrahydrocannabinol (THC) content medical grade cannabis oils from medical cannabis plants using a mobile processing unit designed into a heavy-duty vehicle for on-site operations; Canna-Cures Research & Development Center, Inc., which engages in research and development activities as well as retail and wholesale distribution of medical cannabis products and dietary supplements; and offerings under the EUFLORIA brand name for consumer distribution channels, encompassing botanicals endocannabinoid nutraceuticals, medicinal hemp products, oil-infused items, and private label packaging services. Founded in 1984 and headquartered in Clearwater, Florida, with operational addresses in Silver Spring, Maryland, Acacia Diversified Holdings previously operated as Acacia Automotive, Inc., before changing its name in October 2012 to reflect its pivot to diversified holdings in pharmaceuticals and healthcare services targeting the United States market. The company serves customers in the alternative medicine and nutraceuticals segments, with historical revenue derived primarily from citrus extracts manufacturing and hemp-related activities in the U.S. No major recent partnerships, acquisitions, funding rounds, product launches, or strategic shifts within the last 1-2 years are publicly reported, amid indications of limited operational activity and micro-cap status on OTC markets.